The home dialysis market is growing. Outset Medical's Tablo system has been deemed a substantial clinical improvement over current home dialysis units. With increasing revenues and a growing backlog, ...
SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced that its Tablo® Hemodialysis System has received the first-ever approval from the Centers for Medicare ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medical’s mobile Tablo Hemodialysis System at ...
After raising $125 million for its commercialization efforts earlier this year, portable dialysis machine manufacturer Outset Medical is now going public with a $241.7 million Nasdaq IPO. Trading ...
Please provide your email address to receive an email when new articles are posted on . Outset Medical, maker of the Tablo hemodialysis machine, reported that the device was added to 30 new hospital ...
Please provide your email address to receive an email when new articles are posted on . In a press release, the company said the expansion of its leadership “will help strengthen global operations and ...
Dialysis player Outset Medical attracted a lot of media attention last month when it released an SEC filing for a $60 million equity financing. Now, it's ready to give a much more detailed account of ...
SAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first organization to establish a home hemodialysis program, today announced a collaboration with Outset Medical, Inc ...
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of ...
The Tablo System promises to make dialysis easier and more convenient for patients. But there are significant barriers to the technology. By Dawn MacKeen This article is part of Upstart, a series ...
Outset Medical announced a hold on shipments of its Tablo dialysis system to home users. This hold will be in place until the FDA completes its review of a new regulatory filing. Outset's revenue will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results